Since the reactive microglia in ALS are derived from the endogenous pool and not from the circulating monocytes [10], the endogenous microglial population may act as the predominant source of CHIT-1 in ALS-CSF, thus rendering them as potential clinical targets. This evidence concerns the gene CHIT1 and amyotrophic lateral sclerosis.